Drug intelligence / Profile preview

CAREIMMUN Onco

Development stage
Unknown
Lead developer
biosyn Arzneimittel
Modality
Small Molecules
Administration
Oral
01

Overview

CAREIMMUN Onco is an oral multivitamin and micronutrient food supplement developed by biosyn Arzneimittel GmbH specifically for the nutritional support of patients undergoing cancer treatment or experiencing nutritional stress. The formulation provides a comprehensive blend of essential vitamins (C, D3, E, and B-complex), minerals (zinc, copper, chromium, molybdenum), and trace elements such as selenium. A key feature of the product is the inclusion of high-dose Coenzyme Q10 (50 mg) and bioactive folate in the form of methyltetrahydrofolate, rather than standard folic acid. Notably, CAREIMMUN Onco deliberately excludes iron and beta-carotene to avoid potential tumor-promoting effects or increased health risks in specific populations, such as smokers. The supplement is delivered as capsules containing coated pellets, which can be opened and sprinkled on food if necessary, and is free from common allergens like gluten and lactose.

Brand names
CAREIMMUN Onco
Other names
CAREIMMUN Onco-biosyn Arzneimittel-food supplement-oral

Beyond the preview

Go deeper on CAREIMMUN Onco.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAREIMMUN Onco.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call